Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit
| Autor: | Ismael El Hajra, Virginia Matallana, Elena Pérez, Marta Calvo, Santiago Blanco Rey, María Isabel Vera, Irene González Partida, Yago González-Lama |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty Referral Coronavirus disease 2019 (COVID-19) Inflammatory bowel disease Internal medicine Care activity medicine Humans Retrospective Studies Remote Consultation business.industry Gastroenterology COVID-19 Retrospective cohort study General Medicine Middle Aged medicine.disease Inflammatory Bowel Diseases Spain Hospital admission Observational study Female business Delivery of Health Care Hospital Units |
| Zdroj: | Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 113(2) |
| ISSN: | 1130-0108 |
| Popis: | INTRODUCTION: COVID-19 has altered the usual practice of medicine and the state of emergency declared in Spain on March 14th has considerably changed the activity of inflammatory bowel disease (IBD) units. The aim of this study was to evaluate the consequences of COVID-19 on the IBD Unit's activity and provide information on restructuring with available resources. METHODS: an observational study was performed in a referral hospital in Madrid (Spain). Type of appointment, loss of follow-up, hospital admission, treatment changes, endoscopic activity, surgeries and blood tests were evaluated between March 15th and May 15th, 2020. This data was compared with the usual activity a year before. RESULTS: among the 510 patients included, 476 (93.33 %) received had a remote consultation, representing an increase of 92.38 % compared with the previous year (0.95 %). There was a loss of follow-up in 26 patients (5.1 %) vs 15 (3.58 %) the previous year. A total of 60 (35.09 %) blood tests, 64 (76.19 %) endoscopies and all scheduled surgeries were suspended. Besides, 484 (94.9 %) patients remained adherent vs 417/419 (99.5 %) in the pre-pandemic period and 48 (9.41 %) reported symptoms of an IBD flare. Thirty-nine (7.6 %) patients developed symptoms suggestive of COVID-19. CONCLUSION: a large number of tests and on-site outpatient visit consultations were suspended. However, a rapid adaptation to telemedicine allowed these patients to be closely followed up. Although it was possible to maintain therapeutic compliance, with a loss to follow-up slightly higher than the previous year, suspensions and delays of tests could have significant negative consequences in the long term. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|